Supernus Pharmaceuticals | SUPN - 負債





負債 変化する 日付
Abbott USD 34.05B 20.19B 2026-03
ANI Pharmaceuticals USD 613.76M 3.28M 2026-03
Aurora Cannabis CAD 23.86M 76.48M 2026-03
Bristol-Myers Squibb USD 46.43B 711M 2026-03
Canopy Growth CAD 278.71M 19.38M 2026-03
Cara Therapeutics USD 0 0 2025-03
Corcept Therapeutics USD 9.64M 3.53M 2026-03
Eisai JPY 186.08B 50.58B 2026-03
Eli Lilly USD 43.37B 867M 2026-03
Novo Nordisk DKK 118.72B 61.75B 2025-03
Pacira USD 363.12M 4.53M 2026-06
Perrigo USD 3.63B 7.7M 2026-03
Pfizer USD 63.19B 536M 2026-06
Supernus Pharmaceuticals USD 40.17M 733K 2026-06
United Therapeutics USD 200M 100M 2025-03
Xeris Pharmaceuticals USD 258.55M 899K 2026-03